BioSpace News Archive

Lone Star Bio

Baird Medical Performs First Thyroid Microwave Ablation Procedure in the United States

Baird Medical Devices, Inc. announced that it has performed its first thyroid MWA procedure in the United States since obtaining registration clearance from the U.S. Food and Drug Administration on November 22, 2023.

January 23, 2024
·
4 min read
Policy

FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer

Amadix, a Spanish biotech company, announced that PreveCol®, its colorectal cancer screening blood test, has received Breakthrough Device Designation from the U.S. Food and Drug Administration.

January 23, 2024
·
2 min read
Bio NC

CN Bio and Altis Biosystems Partner to Develop Next-generation Human Gut/Liver in vitro model for Advanced ADME Studies

CN Bio and Altis Biosystems, Inc., leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, announced a strategic partnership.

January 23, 2024
·
3 min read
Business

Enthera Pharmaceuticals Appoints Lisa M. Olson as CEO and Announces Clinical Trial Progress with Ent001

Enthera Pharmaceuticals, a clinical-stage biotech company developing first-in-class antibody therapeutics targeting the Insulin Growth Factor Binding Protein family for selected inflammatory diseases, announced the appointment of Lisa M. Olson, Ph.D., as the company’s Chief Executive Officer.

January 23, 2024
·
5 min read
Business

Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics

HippoFi’s biotechnology business PUR Biologics, proudly announces Scott Bauccio as its new Head of Sales.

January 23, 2024
·
3 min read
Drug Development

Caliway Received First Approval of CBL-514 Pivotal Phase 3 Study Application for Subcutaneous Fat Reduction

Caliway Biopharmaceuticals announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s Pivotal Phase 3 study for subcutaneous fat reduction.

January 23, 2024
·
5 min read
Genetown

Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies

Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the completion of a $75 million Series C financing.

January 23, 2024
·
5 min read
Business

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Synthego and SeQure Dx have announced a strategic partnership to provide CRISPR-based therapeutics developers with comprehensive off-target editing analytical services that include best-in-class technology and turn-key end-to-end development solutions.

January 23, 2024
·
4 min read
Genetown

BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors

BeiGene, Ltd., a global biotechnology company, announced that Olivier Brandicourt, M.D. has been appointed to its Board of Directors.

January 23, 2024
·
5 min read
Business

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

Johnson & Johnson announced results for fourth-quarter and full year 2023. “Johnson & Johnson’s full year 2023 results reflect the breadth and competitiveness of our business and our relentless focus on delivering for patients,” said Joaquin Duato, Chairman and Chief Executive Officer.

January 23, 2024
·
38 min read